PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Huma Therapeutics Limited, London, UK.\', \'Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, London, UK.\', \'Faculty of Medicine, University of Belgrade, Belgrade, Serbia.\', \'Huma Therapeutics Limited, London, UK. david.plans@huma.com.\', \'University of Exeter, SITE, Exeter, UK. david.plans@huma.com.\', \'Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, UK.\', \'Johns Hopkins Bloomberg School Public Health, Baltimore, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-95136-x
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34413324
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all